A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Alectinib Impurity 14 - Request Quote

Picture of Alectinib Impurity 14

Alectinib Impurity 14

SZ CAT No:SZ-A081030
CAS No
NA
Mol.F.
C30H36N4O3
Mol.Wt.
500.6
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Alectinib Impurity 14 is chemically 8-(4-(bis(2-hydroxyethyl)amino)piperidin-1-yl)-9-ethyl-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile. Alectinib Impurity 14 is supplied with detailed characterization data compliant with regulatory guideline. Alectinib Impurity 14 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Alectinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Alectinib Impurity 14

Purchase Alectinib Impurity 14

Alectinib Impurity 14 suppliers

Alectinib Impurity 14 manufacturers

Alectinib Impurity 14 price

Order Alectinib Impurity 14

Enquire Alectinib Impurity 14

Alectinib Impurity 14 cost

Alectinib Impurity 14 Supplier

Alectinib Impurity 14 Distributor

Alectinib Impurity 14 for Method Validation

Alectinib Reference Standard

Alectinib Impurity 14 for ANDA Filing

Alectinib Impurity 14 for Forced Degradation Studies

Alectinib Impurity 14 Identification Standards

Alectinib Impurity 14 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,